Abstract
ObjectivesTo examine the current state of unique device identifier (UDI) implementation, including barriers and facilitators, among eight health systems participating in a research network committed to real-world evidence (RWE) generation for medical devices.DesignMixed methods, including a structured survey and semistructured interviews.SettingEight health systems participating in the National Evaluation System for health Technology research network within the USA.ParticipantsIndividuals identified as being involved in or knowledgeable about UDI implementation or medical device identification from supply chain, information technology and high-volume procedural area(s) in their health system.Main outcomes measuresInterview topics were related to UDI implementation, including barriers and facilitators; UDI use; benefits of UDI adoption; and vision for UDI implementation. Data were analysed using directed content analysis, drawing on prior conceptual models of UDI implementation and the Exploration, Preparation, Implementation, Sustainment framework. A brief survey of health system characteristics and scope of UDI implementation was also conducted.ResultsThirty-five individuals completed interviews. Three of eight health systems reported having implemented UDI. Themes identified about barriers and facilitators to UDI implementation included knowledge of the UDI and its benefits among decision-makers; organisational systems, culture and networks that support technology and workflow changes; and external factors such as policy mandates and technology. A final theme focused on the availability of UDIs for RWE; lack of availability significantly hindered RWE studies on medical devices.ConclusionsUDI adoption within health systems requires knowledge of and impetus to achieve operational and clinical benefits. These are necessary to support UDI availability for medical device safety and effectiveness studies and RWE generation.
Funder
Medical Device Innovation Consortium
U.S. Food and Drug Administration
Subject
Biomedical Engineering,Surgery
Reference34 articles.
1. United States . 21st Century Cures Act. PL 114-255; 2016
2. Food and Drug Administration . Use of real-world evidence to support regulatory decision-making for medical devices; 2017. https://www.fda.gov/media/99447/download [Accessed 01 Aug 2022].
3. Real-world evidence: promise and peril for medical product evaluation;Dhruva;P T,2018
4. Real-World Evidence and Real-World Data for Evaluating Drug Safety and Effectiveness
Cited by
8 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献